Search results
Which Vitamins Are Good For Arthritis?
Shape via Yahoo News· 18 hours agoGeorgiy Brusovanik, MD, an orthopedist and minimally invasive spine surgeon, says there are two main types of arthritis: inflammatory and...
Two Biosimilars Approved in Europe for Autoimmune Disorders
Medscape· 4 days agoThe drugs are intended to treat several types of arthritis, psoriasis, COVID-19, and Crohn's...
Arthritis Medications: NSAIDs, Steroids, Narcotics, Topical Treatments, and More
WebMD· 5 days agoThere are dozens of medications available with or without a prescription to treat the various forms of arthritis. Nonsteroidal anti-inflammatory drugs or NSAIDs are available both over the counter and by prescription.
Johnson & Johnson (NYSE:JNJ) Shares Purchased by Ninety One SA PTY Ltd
ETF DAILY NEWS· 5 days agoNinety One SA PTY Ltd grew its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 21.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC.
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed...
Benzinga· 6 days agoThe confirmatory clinical safety and efficacy study for AVT05, biosimilar candidate to Simponi® and Simponi Aria® (golimumab), met its primary endpoint in patients with moderate to severe rheumatoid
Community Bank N.A. Has $6.75 Million Stake in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 6 hours agoCommunity Bank N.A. lessened its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 3.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC ...
Calamos Wealth Management LLC Has $4.82 Million Holdings in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 4 days agoCalamos Wealth Management LLC raised its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 50.2% in the fourth quarter, according to its most recent 13F filing with the Securities ...
Galapagos (NASDAQ:GLPG) Receives “Equal Weight” Rating from Morgan Stanley
ETF DAILY NEWS· 6 days agoGalapagos (NASDAQ:GLPG – Get Free Report)‘s stock had its “equal weight” rating reissued by equities research analysts at Morgan Stanley in a research report issued to clients and investors ...